Fitbit (NYSE: FIT) reported Q4 earnings at the close of market on Monday. The figures presented in the report exceeded the Street’s estimates for Q4. The outlook provided by the management for 2016 was up to Street’s expectations, but, Q1 guidance fell a little on the lower side. The stock plunged to $14 during pre-market hours owing largely to the weak Q1 outlook. Analysts have also stepped up to update their views and estimates for the stock, most of which have been turned down slightly to account for the sluggish Q1 guidance.

The company reported total revenue of $711.6 million with gross margin of 48.9% and an adjusted EBITDA of $125.3 million. The revenue in the US doubled to that of last year and showed 100% growth with 8.2 million units sold throughout the quarter. The guidance range for 2016 revenue is $2.4 to $2.5 billion.

Leerink Partners feel the stock will not be able to achieve the expected multiple and as a result has downgraded the stock to a Market Perform from an Outperform rating. The price target is also cut heavily down to $18 from $33. Analyst Steven Wardell believes the risk has climbed even higher as the company expects a loaded second half in 2016. The sales trajectory has also deteriorated as of late and there lays an air of uncertainty regarding newer products.

Oppenheimer analyst, Andrew Uerkwitz has maintained an Outperform rating with a PT of $25 as he believes in a Buy Weakness strategy. The analyst seems positive on the stock and has shown likeness to management’s planning during the earnings call discussion. The analyst believes the stock could prove to be very beneficial in the long run.

SunTrust Robinsn Humphrey analyst Robert Peck shares most of his fellow’s opinions at Oppenheimer and has maintained a Buy rating, while, adjusting his PT to $20 from $25. Mr Peck holds a very positive sentiment regarding the stock in the long run.

The stock is currently trading at $14.18, following the earnings report but greater things are expected during the long run.